{
  "package" : "hl7.fhir.r4.core@4.0.1",
  "definition" : null,
  "system" : "http://terminology.hl7.org/CodeSystem/v2-0227",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#status",
    "code" : "status",
    "valueCode" : "deprecated"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#deprecationDate",
    "code" : "deprecationDate",
    "valueDateTime" : "2011-01"
  } ],
  "codesystem" : "76219677-b1d6-52c6-bb38-c6d753c0ddc3",
  "concept_id" : "01af683c-9289-5482-bb24-d75402cfe4be",
  "ancestors" : {
    "PWJ" : 0
  },
  "extension" : [ {
    "url" : "http://hl7.org/fhir/StructureDefinition/codesystem-concept-comments",
    "valueString" : "(includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006",
    "_valueString" : {
      "extension" : [ {
        "url" : "http://hl7.org/fhir/StructureDefinition/translation",
        "extension" : [ {
          "url" : "lang",
          "valueCode" : "nl"
        }, {
          "url" : "content",
          "valueString" : "(inclusief Celltech Medeva Vaccines en Evans Medical Limited) [Inactief - gebruik NOV] CDC wijzigingen op: 14 juli 2006"
        } ]
      } ]
    }
  } ],
  "id" : "85562dae-99cf-4da4-b36d-f45c799b291d",
  "code" : "PWJ",
  "display" : "PowderJect Pharmaceuticals",
  "designation" : [ {
    "use" : {
      "code" : "display",
      "system" : "http://terminology.hl7.org/CodeSystem/designation-usage"
    },
    "value" : "PowderJect Pharmaceuticals",
    "language" : "nl"
  } ],
  "version" : "2.9"
}